High School Principal Reportedly Allowing Pot Smoking in Building
Watch These 4 Marijuana Stocks On Monday (2/25/19)
Canopy Growth initiated as a Hold at Jefferies, but still ‘set up for global domination’
5 Clinical Stage Biotech Stocks to Buy
4 Marijuana Stocks Heating Up On Monday (2/25/19)
These 4 Marijuana Stocks Could Take Off On Monday (2/25/19)
Cronos Group Rises Following Bernstein Initiation, Other Pot Stocks Fall
INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Stockholders With Losses Exceeding $500K of Class Action Against 22nd Century Group, Inc. (XXII) and Lead Plaintiff Deadline March 22, 2019
Cronos falls, Aurora gains after wave of pot-stock initiations
TrustCo Bank CEO sees big raise in 2018, as total compensation tops $2 million
Once Virulently Anti-Cannabis, Calaveras County is Reconsidering Commercial Ban
4 Healthcare Stocks Looking To Kick Off A Strong Week
IIPR Stock Moves Higher after New Debt Is Raised
Tech helps San Francisco DA wipe out 8,000 pot convictions
Jefferies initiates cannabis coverage, says industry could reach $130 billion by 2029
These Two Marijuana Stocks Are Best Poised For World Domination, Analyst Says
Movers after hours: Mosaic, Etsy, Range Resources, Tenet Health, Hertz
Cannabis is the leading cause of fatalities on roadways, says MADD Canada CEO Andrew Murie
Jefferies Names Five Marijuana Stocks To Buy—And Two Not To Buy
3 Under-the-Radar Cannabis Stocks to Buy
Cannabis Stocks Bleeding Today despite New Coverage
Green Growth Brands Falls 4.5% before Its Q2 Earnings Release
Jefferies Bullish On Cannabis Stocks, Highlights Importance Of Medical And Recreational Exposure
Jefferies Analyst Rates Aurora Cannabis and 4 Other Pot Stocks as Buys
CannTrust's stock turns lower in NYSE debut, but Jefferies says 'buy'
1 Marijuana Stock to Buy, 1 to Hold, and 1 to Sell
INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders With Losses Exceeding $500K of Class Action Against 22nd Century Group, Inc. (XXII) and Lead Plaintiff Deadline March 22, 2019
What Analysts Are Recommending for Trulieve Cannabis
‘PILL’ ETF Gains on $21.4B GE Biopharma Business Sale
BB&T Corporation CEO to Speak at RBC Capital Markets Financial Institutions Conference
3 Stocks to Buy and Hold for Decades
iAnthus Capital Holdings Gained 6.4% Last Week
Bodenholm Capital’s Returns, AUM and Holdings